Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

Staff  |  August 1, 2009

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.

2009 Annual Meeting Goes Beyond the Basics for Basic Researchers

Staff  |  August 1, 2009

Attendees at the 2009 ACR/ ARHP Annual Scientific Meeting will find multiple opportunities to increase their knowledge.

Doused in Denmark

David S. Pisetsky, MD, PhD  |  August 1, 2009

EULAR captured the complex picture of rheumatology’s future

Productive Partnership

Sherine Gabriel, MD, and Leslie J. Crofford, MD  |  August 1, 2009

The ACR and the REF work closely to support the future of rheumatology

Tailor the Message for Arthritis Self-Care

Gretchen Henkel  |  July 1, 2009

Delving into patients’ perceptions of self-management activities

Closer to a Cure

Staff  |  July 1, 2009

Over the last two years, the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign has granted almost $9 million to 30 researchers in the hopes of finding a cure for rheumatoid arthritis (RA). These researchers are studying an array of issues, from innovative research into the genetics of RA to new treatments that will more effectively manage the disease. With the REF’s announcement of the third round of Within Our Reach grant recipients, patients with RA are closer to a cure.

Board Members Lobby Congress on Arthritis Act and Other Legislative Priorities

From the College  |  July 1, 2009

The ACR board of directors met in Washington, D.C. May 13–15. The trip began with the board and staff participating in Congressional Insight, a computer-simulation exercise that allows participants to experience some of the pressures and rewards of being a U.S. representative.

Round One for PQRI

Kurt Ullman  |  July 1, 2009

Complex requirements and confusion typify start of Medicare quality initiative

Summer of ’09 is Health Reform Time

Staff  |  June 1, 2009

This summer is an important time for healthcare. Congress and President Barak Obama’s administration are dedicated to creating comprehensive healthcare reform to ensure quality healthcare for all, while considering all aspects of healthcare delivery. Their goal is to create this legislative package this summer.

We Are All in This Together

Leslie Crofford, MD  |  June 1, 2009

While rheumatologists in private practice face daily concerns regarding reimbursements and certifications, the Research and Education Foundation (REF) is working behind the scenes to help improve patients’ lives. Through its balanced core awards and grants portfolio, the REF supports education, training, and career development for the future academic workforce.

  • « Previous Page
  • 1
  • …
  • 286
  • 287
  • 288
  • 289
  • 290
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences